Sponsor pipeline

Nordic Lymphoma Group clinical trial pipeline

3 active trials 2 recruiting 1 Phase 3 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2		1
Phase 3		1

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT04332822	A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With…	DLBCL	Recruiting	2024-09-19
Phase 2
NCT05214183	Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma	MCL	Active, Not Recruiting	2024-02-12
Not specified
NCT06755619	CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent…	Primary Central Nervous System (CNS) Lymphoma	Recruiting	2025-01-01

Get alerts when Nordic Lymphoma Group's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.